MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$153,942K
Net Income Loss
-$153,942K
Loss before
provision for income taxes
-$151,942K
Provision for income taxes
$2,000K
Interest income
$2,875K
Loss from operations
-$152,632K
License revenue
$10,844K
Interest expense
$2,185K
Total operating
expenses
$163,476K
Research and development
$138,086K
General and
administrative
$25,390K
Back
Back
Income Statement
source: myfinsight.com
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)